| Organism name | Cinnamomum tenuifolium | 
|---|---|
| Genus | Cinnamomum | 
| Family | Lauraceae | 
| Kingdom | Plantae | 
| Linked NCBI taxonomy name | Cinnamomum | 
|---|---|
| Linked NCBI taxonomy ID | 13428 | 
| Linked level | genus | 
| Family in NCBI taxonomy | Lauraceae | 
|---|---|
| ID | 3433 | 
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae | 
|---|---|
| ID | 33090 | 
| Plant class | Magnoliophyta | 
|---|---|
| ID | 3398 | 
| KNApSAcK ID | name | ChEMBL link | CTD link | # of proteins in ChEMBL interaction / related OMIM / related KEGG DISEASE | # of genes in CTD interaction / related diseases | KCF-S cluster | phytochemical cluster | figure | 
|---|---|---|---|---|---|---|---|---|
| C00002631   | (+)-Lirioresinol B / (+)-Syringaresinol | CHEMBL361362 CHEMBL402653 | C042192 | 1 / 0 / 0 | No. 38 | No. 21 |   | |
| C00032301   | Tenuifolin | No. 50 | No. 51 |   | ||||
| C00029821   | Sitostenone / beta-Sitostenone / Stigmast-4-en-3-one / Stigmast-4-ene-3-one | CHEMBL66926 | No. 53 | No. 11 |   | |||
| C00003672   | Sitosterol / beta-sitosterl / (-)-beta-Sitosterol / Stigmast-5-en-3beta-ol | CHEMBL221542 CHEMBL1398443 CHEMBL1875388 | 17 / 19 / 12 | No. 53 | No. 11 |   | ||
| C00001233   | Palmitic acid | CHEMBL82293 | D019308 | 16 / 8 / 8 | 35 / 1 | No. 184 | No. 68 |   | 
| C00001238   | Stearic acid | CHEMBL46403 | C031183 | 15 / 17 / 19 | 6 / 1 | No. 184 | No. 68 |   | 
| C00047930   | Isoobtusilactone A | CHEMBL449423 CHEMBL490165 | No. 329 |   | ||||
| C00048028   | Obtusilactone A | CHEMBL449423 CHEMBL490165 | No. 329 |   | ||||
| C00031628   | beta-Sitosteryl-D-glucoside | CHEMBL197711 CHEMBL506678 CHEMBL2304043 | 5 / 4 / 2 | No. 520 |   | |||
| C00000601   | (+)-Sesamin | CHEMBL43469 CHEMBL252915 CHEMBL1572261 CHEMBL1591714 CHEMBL1708854 CHEMBL1904496 CHEMBL1968861 | C054125 | 20 / 24 / 15 | 0 / 5 | No. 621 | No. 21 |   | 
| C00047668   | 4-Allylcatechol | CHEMBL111134 | C051268 | 8 / 0 | No. 1114 | No. 6 |   | |
| C00002743   | Ferulic acid / 3-(4-Hydroxy-3-methoxyphenyl)-2-propenoic acid | CHEMBL32749 | C004999 | 110 / 52 / 40 | 16 / 6 | No. 1366 | No. 6 |   | 
| C00002762   | Myristicin | CHEMBL481044 | C005246 | 6 / 4 / 2 | 2 / 0 | No. 1917 | No. 6 |   | 
| C00048118   | Secotenuifolide A | CHEMBL1078158 | No. 2005 |   | ||||
| C00002657   | p-Formylphenol / 4-Hydroxybenzaldehyde / p-Hydroxybenzaldehyde | CHEMBL14193 | C011483 | 3 / 2 / 2 | No. 2076 |   | ||
| C00048189   | Tenuifolide A | CHEMBL1077732 CHEMBL1077858 | No. 3105 |   | ||||
| C00047932   | Isotenuifolide A | CHEMBL1077732 CHEMBL1077858 | No. 3105 |   | ||||
| C00048190   | Tenuifolide B / (-)-Tenuifolide B | CHEMBL1078157 | No. 5104 |   | ||||
| C00047706   | Alpinenone | CHEMBL1077895 | No. 7743 |   | 
| accession | description | class description | KNApSAcK metabolite in interactions | # of diseases (OMIM / KEGG) | 
|---|---|---|---|---|
| O75496 | Geminin | Unclassified protein | C00000601 C00001233 C00002743 C00002762 | 0 / 0 | 
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000601 C00002743 C00002762 C00003672 | 0 / 1 | 
| P03372 | Estrogen receptor | NR3A1 | C00001233 C00002743 C00003672 | 1 / 1 | 
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000601 C00002743 C00003672 | 1 / 0 | 
| P04150 | Glucocorticoid receptor | NR3C1 | C00001233 C00001238 C00002743 | 0 / 1 | 
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000601 C00002743 C00003672 | 0 / 1 | 
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000601 C00002743 C00003672 | 1 / 1 | 
| P08047 | Transcription factor Sp1 | Unclassified protein | C00001233 C00003672 C00031628 | 0 / 0 | 
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00002743 C00003672 | 0 / 0 | 
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00000601 C00002743 | 0 / 0 | 
| P14679 | Tyrosinase | Oxidoreductase | C00002743 C00003672 | 4 / 2 | 
| P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00001233 C00001238 | 2 / 2 | 
| Q16637 | Survival motor neuron protein | Unclassified protein | C00000601 C00002762 | 4 / 1 | 
| Q9UNA4 | DNA polymerase iota | Enzyme | C00000601 C00002762 | 0 / 0 | 
| P06746 | DNA polymerase beta | Enzyme | C00003672 C00031628 | 0 / 0 | 
| P00734 | Prothrombin | S1A | C00003672 C00031628 | 4 / 2 | 
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00000601 C00001233 | 0 / 0 | 
| P49841 | Glycogen synthase kinase-3 beta | Gsk | C00003672 C00031628 | 0 / 0 | 
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00001238 C00002743 | 0 / 0 | 
| P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00003672 C00031628 | 0 / 0 | 
| P11473 | Vitamin D3 receptor | NR1I1 | C00000601 C00001238 | 2 / 3 | 
| P11387 | DNA topoisomerase 1 | Isomerase | C00001233 C00002631 | 0 / 0 | 
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00001238 C00003672 | 1 / 1 | 
| P08183 | Multidrug resistance protein 1 | drug | C00001233 C00003672 | 1 / 0 | 
| P16473 | Thyrotropin receptor | Glycohormone receptor | C00001238 C00003672 | 3 / 2 | 
| P15090 | Fatty acid-binding protein, adipocyte | Other cytosolic protein | C00001233 C00001238 | 0 / 0 | 
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00000601 | 0 / 0 | 
| P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00002743 | 1 / 1 | 
| P10828 | Thyroid hormone receptor beta | NR1A2 | C00001238 | 3 / 1 | 
| P51649 | Succinate-semialdehyde dehydrogenase, mitochondrial | Oxidoreductase | C00002657 | 1 / 1 | 
| P00918 | Carbonic anhydrase 2 | Lyase | C00002743 | 1 / 2 | 
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00002743 | 0 / 1 | 
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00002743 | 1 / 1 | 
| P25021 | Histamine H2 receptor | Histamine receptor | C00002743 | 0 / 0 | 
| P35367 | Histamine H1 receptor | Histamine receptor | C00002743 | 0 / 0 | 
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00002743 | 1 / 0 | 
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00002743 | 0 / 0 | 
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00002743 | 0 / 0 | 
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00002743 | 0 / 0 | 
| P34969 | 5-hydroxytryptamine receptor 7 | Serotonin receptor | C00002743 | 0 / 0 | 
| P14780 | Matrix metalloproteinase-9 | M10A | C00002743 | 2 / 2 | 
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00002743 | 0 / 0 | 
| P06241 | Tyrosine-protein kinase Fyn | Src | C00002743 | 0 / 0 | 
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00002743 | 0 / 0 | 
| Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00002762 | 0 / 0 | 
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00002743 | 1 / 8 | 
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00002743 | 0 / 0 | 
| P17252 | Protein kinase C alpha type | Alpha | C00002743 | 0 / 0 | 
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00002743 | 2 / 0 | 
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00002743 | 0 / 0 | 
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00002743 | 0 / 0 | 
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00002743 | 0 / 0 | 
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00002743 | 0 / 0 | 
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00002743 | 0 / 0 | 
| P23280 | Carbonic anhydrase 6 | Lyase | C00002743 | 0 / 0 | 
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00002743 | 0 / 0 | 
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00002743 | 1 / 1 | 
| O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00000601 | 0 / 0 | 
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00002743 | 0 / 0 | 
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00002743 | 1 / 0 | 
| Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00002743 | 0 / 0 | 
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00002762 | 0 / 0 | 
| O43570 | Carbonic anhydrase 12 | Lyase | C00002743 | 1 / 2 | 
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00002743 | 0 / 0 | 
| Q8TDS4 | Hydroxycarboxylic acid receptor 2 | Hydroxycarboxylic acid receptor | C00002743 | 0 / 0 | 
| P14902 | Indoleamine 2,3-dioxygenase 1 | Enzyme | C00002657 | 0 / 0 | 
| P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00000601 | 2 / 0 | 
| P29466 | Caspase-1 | C14 | C00002743 | 0 / 0 | 
| P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00002743 | 0 / 0 | 
| P43166 | Carbonic anhydrase 7 | Lyase | C00002743 | 0 / 0 | 
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00002743 | 0 / 0 | 
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00002743 | 0 / 0 | 
| P30988 | Calcitonin receptor | Calcitonin receptor | C00002743 | 0 / 0 | 
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00002743 | 1 / 0 | 
| P41143 | Delta-type opioid receptor | Opioid receptor | C00002743 | 0 / 0 | 
| Q92731 | Estrogen receptor beta | NR3A2 | C00002743 | 0 / 1 | 
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00002743 | 0 / 0 | 
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00002743 | 0 / 0 | 
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00002743 | 0 / 0 | 
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00002743 | 1 / 0 | 
| P12104 | Fatty acid-binding protein, intestinal | Other cytosolic protein | C00001233 | 0 / 0 | 
| P00915 | Carbonic anhydrase 1 | Lyase | C00002743 | 0 / 0 | 
| P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00002743 | 0 / 0 | 
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00002743 | 0 / 0 | 
| P08311 | Cathepsin G | S1A | C00002743 | 0 / 0 | 
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00002743 | 1 / 0 | 
| P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00000601 | 0 / 0 | 
| P03956 | Interstitial collagenase | M10A | C00002743 | 0 / 1 | 
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00002743 | 0 / 0 | 
| P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00000601 | 7 / 3 | 
| Q9UGP5 | DNA polymerase lambda | Enzyme | C00001238 | 0 / 0 | 
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00000601 | 0 / 0 | 
| Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00002743 | 0 / 0 | 
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00002743 | 0 / 0 | 
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00002743 | 0 / 0 | 
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00002743 | 2 / 0 | 
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00002743 | 0 / 0 | 
| Q13093 | Platelet-activating factor acetylhydrolase | Enzyme | C00002743 | 3 / 0 | 
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00002743 | 0 / 0 | 
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00002743 | 0 / 0 | 
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00002743 | 2 / 0 | 
| P80404 | 4-aminobutyrate aminotransferase, mitochondrial | Transferase | C00002657 | 1 / 1 | 
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00002743 | 5 / 9 | 
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00002743 | 1 / 0 | 
| P21452 | Substance-K receptor | Neurokinin receptor | C00002743 | 0 / 0 | 
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00002743 | 0 / 0 | 
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00002743 | 3 / 0 | 
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00002743 | 0 / 0 | 
| Q96RI1 | Bile acid receptor | NR1H4 | C00001233 | 0 / 0 | 
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00002743 | 1 / 0 | 
| P08246 | Neutrophil elastase | S1A | C00002743 | 2 / 1 | 
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00002743 | 2 / 1 | 
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00002743 | 2 / 2 | 
| Q16790 | Carbonic anhydrase 9 | Lyase | C00002743 | 0 / 1 | 
| Q01469 | Fatty acid-binding protein, epidermal | Other cytosolic protein | C00001233 | 0 / 0 | 
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00001238 | 3 / 3 | 
| P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00000601 | 2 / 2 | 
| P05413 | Fatty acid-binding protein, heart | Other cytosolic protein | C00001233 | 0 / 0 | 
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00002743 | 0 / 0 | 
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00002743 | 0 / 3 | 
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00002743 | 1 / 0 | 
| P22303 | Acetylcholinesterase | Hydrolase | C00002743 | 1 / 0 | 
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00002743 | 0 / 0 | 
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00002743 | 0 / 0 | 
| P35372 | Mu-type opioid receptor | Opioid receptor | C00002743 | 0 / 0 | 
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00002743 | 0 / 0 | 
| P25103 | Substance-P receptor | Neurokinin receptor | C00002743 | 0 / 0 | 
| P25105 | Platelet-activating factor receptor | PAF receptor | C00002743 | 0 / 0 | 
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00002743 | 0 / 0 | 
| P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00001238 | 0 / 0 | 
| P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00001238 | 0 / 0 | 
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00002743 | 0 / 0 | 
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00003672 | 2 / 0 | 
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00002743 | 0 / 0 | 
| O60603 | Toll-like receptor 2 | Membrane receptor | C00001233 | 1 / 1 | 
| P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00002743 | 5 / 1 | 
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00000601 | 4 / 3 | 
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00000601 | 0 / 0 | 
| P10275 | Androgen receptor | NR3C4 | C00001233 | 3 / 4 | 
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00002743 | 1 / 1 | 
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00002743 | 0 / 0 | 
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00002743 | 0 / 0 | 
| Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00001233 | 0 / 0 | 
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00002743 | 0 / 0 | 
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00002743 | 1 / 1 | 
| P07451 | Carbonic anhydrase 3 | Lyase | C00002743 | 0 / 0 | 
| P06239 | Tyrosine-protein kinase Lck | Src | C00002743 | 0 / 1 | 
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00002743 | 0 / 0 | 
| P22748 | Carbonic anhydrase 4 | Lyase | C00002743 | 1 / 1 | 
| P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | Enzyme | C00003672 | 1 / 1 | 
| Q12794 | Hyaluronidase-1 | Enzyme | C00002743 | 1 / 2 | 
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00001238 | 0 / 0 | 
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002743 | 0 / 0 | 
| P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00002743 | 3 / 0 | 
| O00255 | Menin | Unclassified protein | C00001238 | 2 / 5 | 
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001238 | 1 / 2 | 
| Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00000601 | 1 / 1 | 
| gene | gene name | gene description | KNApSAcK metabolite in interactions | 
|---|---|---|---|
| 1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | C00002743
                          C00002762 | 
| 10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | C00001233
                          C00001238 | 
| 5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha | C00001233
                          C00001238 | 
| 3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 | C00001233
                          C00001238 | 
| 1906 | EDN1, ET1, HDLCQ7, PPET1 | endothelin 1 | C00001233
                          C00001238 | 
| 6348 | CCL3, G0S19-1, LD78ALPHA, MIP-1-alpha, MIP1A, SCYA3 | chemokine (C-C motif) ligand 3 | C00001233
                          C00001238 | 
| 9619 | ABCG1, ABC8, WHITE1 | ATP-binding cassette, sub-family G (WHITE), member 1 | C00001233
                          C00001238 | 
| 5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | C00002743
                          C00047668 | 
| 7172 | TPMT | thiopurine S-methyltransferase (EC:2.1.1.67) | C00047668 | 
| 5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 | C00002743 | 
| 6319 | SCD, FADS5, MSTP008, SCD1, SCDOS | stearoyl-CoA desaturase (delta-9-desaturase) (EC:1.14.19.1) | C00002743 | 
| 7299 | TYR, ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3 | tyrosinase (EC:1.14.18.1) | C00002743 | 
| 54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) | C00002743 | 
| 54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) | C00002743 | 
| 54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) | C00002743 | 
| 54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) | C00002743 | 
| 1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) | C00002762 | 
| 5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) | C00002743 | 
| 5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) | C00002743 | 
| 23621 | BACE1, ASP2, BACE, HSPC104 | beta-site APP-cleaving enzyme 1 (EC:3.4.23.46) | C00002743 | 
| 1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | C00002743 | 
| 1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | C00002743 | 
| 595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 | C00002743 | 
| 23563 | CHST5, I-GlcNAc-6-ST, I-GlcNAc6ST, glcNAc6ST-3, gn6st-3, hIGn6ST | carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5 | C00047668 | 
| 4166 | CHST6, MCDC1 | carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6 | C00047668 | 
| 56548 | CHST7, C6ST-2, GST-5 | carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7 (EC:2.8.2.17) | C00047668 | 
| 1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) | C00047668 | 
| 2953 | GSTT2, GSTT2B | glutathione S-transferase theta 2 (EC:2.5.1.18) | C00047668 | 
| 8520 | HAT1, KAT1 | histone acetyltransferase 1 (EC:2.3.1.48) | C00047668 | 
| 5742 | PTGS1, COX1, COX3, PCOX1, PES-1, PGG/HS, PGHS-1, PGHS1, PHS1, PTGHS | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | C00002743 | 
| 207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | C00001233 | 
| 213 | ALB, PRO0883, PRO0903, PRO1341 | albumin | C00001233 | 
| 581 | BAX, BCL2L4 | BCL2-associated X protein | C00001233 | 
| 596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 | C00001233 | 
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | C00001233 | 
| 840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) | C00001233 | 
| 1374 | CPT1A, CPT1, CPT1-L, L-CPT1 | carnitine palmitoyltransferase 1A (liver) (EC:2.3.1.21) | C00001233 | 
| 2876 | GPX1, GPXD, GSHPX1 | glutathione peroxidase 1 (EC:1.11.1.9) | C00001233 | 
| 3034 | HAL, HIS, HSTD | histidine ammonia-lyase (EC:4.3.1.3) | C00001233 | 
| 57817 | HAMP, HEPC, HFE2B, LEAP1, PLTR | hepcidin antimicrobial peptide | C00001233 | 
| 3481 | IGF2, C11orf43, IGF-II, PP9974 | insulin-like growth factor 2 (somatomedin A) | C00001233 | 
| 3630 | INS, IDDM2, ILPR, IRDN, MODY10 | insulin | C00001233 | 
| 1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) | C00001233 | 
| 5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) | C00001233 | 
| 5601 | MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK | mitogen-activated protein kinase 9 (EC:2.7.11.24) | C00001233 | 
| 4493 | MT1E, MT1, MTD | metallothionein 1E | C00001233 | 
| 4494 | MT1F, MT1 | metallothionein 1F | C00001233 | 
| 4496 | MT1H, MT-0, MT-1H, MT-IH, MT1 | metallothionein 1H | C00001233 | 
| 4501 | MT1X, MT-1l, MT1 | metallothionein 1X | C00001233 | 
| 4502 | MT2A, MT2 | metallothionein 2A | C00001233 | 
| 4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) | C00001233 | 
| 3651 | PDX1, GSF, IDX-1, IPF1, IUF1, MODY4, PDX-1, STF-1 | pancreatic and duodenal homeobox 1 | C00001233 | 
| 29893 | PSMC3IP, GT198, HOP2, HUMGT198A, ODG3, TBPIP | PSMC3 interacting protein | C00001233 | 
| 5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A | C00001233 | 
| 5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | C00001233 | 
| 6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) | C00001233 | 
| 23216 | TBC1D1, TBC, TBC1 | TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 | C00001233 | 
| 7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor | C00001233 | 
| 7351 | UCP2, BMIQ4, SLC25A8, UCPH | uncoupling protein 2 (mitochondrial, proton carrier) | C00001233 | 
| OMIM | preferred title | UniProt | 
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency | Q99714 | 
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism | P20309 | 
| #219080 | Acth-independent macronodular adrenal hyperplasia; aimah | P63092 | 
| #103470 | Albinism, ocular, with sensorineural deafness | P14679 | 
| #203100 | Albinism, oculocutaneous, type ia; oca1a | P14679 | 
| #606952 | Albinism, oculocutaneous, type ib; oca1b | P14679 | 
| #103780 | Alcohol dependence | P08172 P14416 P31645 | 
| #612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 | Q13148 | 
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 | Q99720 | 
| #300068 | Androgen insensitivity syndrome; ais | P10275 | 
| #312300 | Androgen insensitivity, partial; pais | P10275 | 
| #218030 | Apparent mineralocorticoid excess; ame | P80365 | 
| #613546 | Aromatase deficiency | P11511 | 
| #139300 | Aromatase excess syndrome; aexs | P11511 | 
| #600807 | Asthma, susceptibility to | Q13093 | 
| #601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 | P22309 | 
| #602025 | Body mass index quantitative trait locus 9; bmiq9 | P41968 | 
| #300615 | Brunner syndrome | P21397 | 
| #114500 | Colorectal cancer; crc | P84022 | 
| #218800 | Crigler-najjar syndrome, type i | P22309 P22310 | 
| #606785 | Crigler-najjar syndrome, type ii | P22309 P22310 | 
| #162800 | Cyclic neutropenia | P08246 | 
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 | P51681 | 
| #119900 | Digital clubbing, isolated congenital | P15428 | 
| #609535 | Drug metabolism, poor, cyp2c19-related | P33261 | 
| #608902 | Drug metabolism, poor, cyp2d6-related | P10635 | 
| #615363 | Estrogen resistance; estrr | P03372 | 
| #600274 | Frontotemporal dementia; ftd | P10636 | 
| #613163 | Gaba-transaminase deficiency | P80404 | 
| #613659 | Gastric cancer | P04626 | 
| #137215 | Gastric cancer, hereditary diffuse; hdgc | P04626 | 
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd | P24557 | 
| #143500 | Gilbert syndrome | P22309 P22310 | 
| #137800 | Glioma susceptibility 1; glm1 | P04626 | 
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay | Q03164 | 
| #609423 | Human immunodeficiency virus type 1, susceptibility to | P41597 P51681 | 
| #237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn | P22309 | 
| #143860 | Hyperchlorhidrosis, isolated | O43570 | 
| #145000 | Hyperparathyroidism 1; hrpt1 | O00255 | 
| #603373 | Hyperthyroidism, familial gestational | P16473 | 
| #609152 | Hyperthyroidism, nonautoimmune | P16473 | 
| #259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 | P15428 | 
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 | P16473 | 
| #147050 | Ige responsiveness, atopic; iger | Q13093 | 
| #612244 | Inflammatory bowel disease 13; ibd13 | P08183 | 
| #603932 | Intervertebral disc disease; idd | P14780 | 
| #246300 | Leprosy, susceptibility to, 3; lprs3 | O60603 | 
| #613795 | Loeys-dietz syndrome, type 3; lds3 | P84022 | 
| #613688 | Long qt syndrome 2; lqt2 | Q12809 | 
| #211980 | Lung cancer | P00533 P04626 | 
| #608516 | Major depressive disorder; mdd | P08172 | 
| #174800 | Mccune-albright syndrome; mas | P63092 | 
| #300705 | Mental retardation, x-linked 17; mrx17 | Q99714 | 
| %300852 | Mental retardation, x-linked 88; mrx88 | P50052 | 
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 | Q99714 | 
| #613073 | Metaphyseal anadysplasia 2; mandp2 | P14780 | 
| #601492 | Mucopolysaccharidosis, type ix; mps9 | Q12794 | 
| #131100 | Multiple endocrine neoplasia, type i; men1 | O00255 | 
| #126200 | Multiple sclerosis, susceptibility to; ms | P08575 | 
| #607948 | Mycobacterium tuberculosis, susceptibility to | P11473 | 
| #159900 | Myoclonic dystonia | P14416 | 
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 | P08246 | 
| #601665 | Obesity | P32245 | 
| #164230 | Obsessive-compulsive disorder; ocd | P31645 | 
| #604715 | Orthostatic intolerance | P23975 | 
| #166350 | Osseous heteroplasia, progressive; poh | P63092 | 
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 | P00918 | 
| #167000 | Ovarian cancer | P04626 | 
| #260540 | Parkinson-dementia syndrome | P10636 | 
| #613135 | Parkinsonism-dystonia, infantile; pkdys | Q01959 | 
| #172700 | Pick disease of brain | P10636 | 
| #102200 | Pituitary adenoma, growth hormone-secreting | P63092 | 
| #614278 | Platelet-activating factor acetylhydrolase deficiency; pafad | Q13093 | 
| #614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 | P00734 | 
| #613679 | Prothrombin deficiency, congenital | P00734 | 
| #103580 | Pseudohypoparathyroidism, type ia; php1a | P63092 | 
| #603233 | Pseudohypoparathyroidism, type ib; php1b | P63092 | 
| #612462 | Pseudohypoparathyroidism, type ic; php1c | P63092 | 
| #607276 | Resting heart rate, variation in | P08588 | 
| #600852 | Retinitis pigmentosa 17; rp17 | P22748 | 
| #604906 | Schizophrenia 9; sczd9 | P49798 | 
| #181500 | Schizophrenia; sczd | P49798 | 
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive | P08575 | 
| #609620 | Short qt syndrome 1; sqt1 | Q12809 | 
| #601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 | P14679 | 
| #313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 | P10275 | 
| #253300 | Spinal muscular atrophy, type i; sma1 | Q16637 | 
| #253550 | Spinal muscular atrophy, type ii; sma2 | Q16637 | 
| #253400 | Spinal muscular atrophy, type iii; sma3 | Q16637 | 
| #271150 | Spinal muscular atrophy, type iv; sma4 | Q16637 | 
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 | Q9NUW8 | 
| #601367 | Stroke, ischemic | P00734 | 
| #271980 | Succinic semialdehyde dehydrogenase deficiency; ssadhd | P51649 | 
| #601104 | Supranuclear palsy, progressive, 1; psnp1 | P10636 | 
| #188050 | Thrombophilia due to thrombin defect; thph1 | P00734 | 
| #188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth | P10828 | 
| #274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth | P10828 | 
| #145650 | Thyroid hormone resistance, selective pituitary; prth | P10828 | 
| #190300 | Tremor, hereditary essential, 1; etm1 | P35462 | 
| #277440 | Vitamin d-dependent rickets, type 2a; vddr2a | P11473 | 
| #610379 | West nile virus, susceptibility to | P51681 | 
| #278300 | Xanthinuria, type i | P47989 | 
| #112100 | Yt blood group antigen | P22303 | 
| KEGG | name | UniProt | 
|---|---|---|
| H00033 | Adrenal carcinoma | O00255
                            (related) | 
| H00034 | Carcinoid | O00255
                            (related) | 
| H00045 | Malignant islet cell carcinoma | O00255
                            (related) | 
| H00246 | Primary hyperparathyroidism | O00255
                            (related) | 
| H01102 | Pituitary adenomas | O00255
                            (related) | 
| H01302 | Hyperchlorhidrosis isolated (HCHLH) | O43570
                            (related) | 
| H00021 | Renal cell carcinoma | O43570
                            (marker) Q16790 (marker) | 
| H00344 | Leprosy | O60603
                            (related) | 
| H00016 | Oral cancer | P00533
                            (related) P00533 (marker) | 
| H00017 | Esophageal cancer | P00533
                            (related) P35354 (related) | 
| H00018 | Gastric cancer | P00533
                            (related) P04626 (related) | 
| H00022 | Bladder cancer | P00533
                            (related) P04626 (related) | 
| H00028 | Choriocarcinoma | P00533
                            (related) P03956 (related) P04626 (related) | 
| H00030 | Cervical cancer | P00533
                            (related) P04626 (related) | 
| H00042 | Glioma | P00533
                            (related) P00533 (marker) | 
| H00055 | Laryngeal cancer | P00533
                            (related) P00533 (marker) | 
| H00223 | Inherited thrombophilia | P00734
                            (related) | 
| H01254 | Congenital prothrombin deficiency | P00734
                            (related) | 
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) | P00918
                            (related) | 
| H00436 | Osteopetrosis | P00918
                            (related) | 
| H00026 | Endometrial Cancer | P03372
                            (marker) P04626 (related) Q92731 (marker) | 
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) | P04150
                            (related) P11511 (related) | 
| H00019 | Pancreatic cancer | P04626
                            (related) | 
| H00027 | Ovarian cancer | P04626
                            (related) | 
| H00031 | Breast cancer | P04626
                            (related) P04626 (marker) | 
| H00046 | Cholangiocarcinoma | P04626
                            (related) P35354 (related) | 
| H00093 | Combined immunodeficiencies (CIDs) | P06239
                            (related) | 
| H00079 | Asthma | P07550
                            (related) | 
| H00100 | Neutropenic disorders | P08246
                            (related) | 
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) | P08575
                            (related) | 
| H00036 | Osteosarcoma | P08684
                            (marker) | 
| H00024 | Prostate cancer | P10275
                            (related) | 
| H00062 | Spinal and bulbar muscular atrophy (SBMA) | P10275
                            (related) | 
| H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) | P10275
                            (related) | 
| H00609 | 46,XY disorders of sex development (Other) | P10275
                            (related) | 
| H00058 | Amyotrophic lateral sclerosis (ALS) | P10636
                            (related) Q13148 (related) | 
| H00077 | Progressive supranuclear palsy (PSP) | P10636
                            (related) | 
| H00078 | Frontotemporal lobar degeneration (FTLD) | P10636
                            (related) | 
| H00249 | Thyroid hormone resistance syndrome | P10828
                            (related) | 
| H00342 | Tuberculosis | P11473
                            (related) | 
| H00784 | Localized autosomal recessive hypotrichosis | P11473
                            (related) | 
| H01143 | Vitamin D-dependent rickets | P11473
                            (related) | 
| H00794 | Aromatase excess syndrome | P11511
                            (related) | 
| H01205 | Coumarin resistance | P11712
                            (related) | 
| H00168 | Oculocutaneous albinism (OCA) | P14679
                            (related) | 
| H00038 | Malignant melanoma | P14679
                            (marker) | 
| H00025 | Penile cancer | P14780
                            (related) P35354 (related) | 
| H00479 | Metaphyseal dysplasias | P14780
                            (related) | 
| H00457 | Primary hypertrophic osteoarthropathy (PHO) | P15428
                            (related) | 
| H01246 | Isolated congenital nail clubbing (ICNC) | P15428
                            (related) | 
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) | P16473
                            (related) | 
| H01269 | Congenital hyperthyroidism | P16473
                            (related) | 
| H00548 | Brunner syndrome | P21397
                            (related) | 
| H00208 | Hyperbilirubinemia | P22309
                            (related) | 
| H00527 | Retinitis pigmentosa (RP) | P22748
                            (related) | 
| H01031 | Orthostatic intolerance (OI) | P23975
                            (related) | 
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) | P24557
                            (related) | 
| H01171 | Poor drug metabolism (PM) | P33261
                            (related) | 
| H00192 | Xanthinuria | P47989
                            (related) | 
| H00480 | Non-syndromic X-linked mental retardation | P50052
                            (related) Q99714 (related) | 
| H00835 | Succinic semialdehyde dehydrogenase (SSADH) deficiency | P51649
                            (related) | 
| H00244 | Pseudohypoparathyroidism | P63092
                            (related) | 
| H00441 | Progressive osseous heteroplasia (POH) | P63092
                            (related) | 
| H00501 | Fibrous dysplasia, polyostotic | P63092
                            (related) | 
| H00259 | Apparent mineralocorticoid excess syndrome | P80365
                            (related) | 
| H01257 | GABA-transaminase deficiency | P80404
                            (related) | 
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) | Q03164
                            (related) Q03164 (marker) | 
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) | Q03164
                            (related) | 
| H00133 | Mucopolysaccharidosis type IX (MPS9) | Q12794
                            (related) | 
| H00421 | Mucopolysaccharidosis (MPS) | Q12794
                            (related) | 
| H00720 | Long QT syndrome | Q12809
                            (related) | 
| H00725 | Short QT syndrome | Q12809
                            (related) | 
| H00455 | Spinal muscular atrophy (SMA) | Q16637
                            (related) | 
| H00658 | Syndromic X-linked mental retardation | Q99714
                            (related) | 
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency | Q99714
                            (related) | 
| H00063 | Spinocerebellar ataxia (SCA) | Q9NUW8
                            (related) | 
| MESH or OMIM | name | KNApSAcK metabolite | 
|---|---|---|
| D003072 | Cognition Disorders | C00001238 C00001233 | 
| D050197 | Atherosclerosis | C00002743 | 
| D007249 | Inflammation | C00002743 | 
| D008106 | Liver Cirrhosis, Experimental | C00002743 | 
| D008545 | Melanoma | C00002743 | 
| D009203 | Myocardial Infarction | C00002743 | 
| D002252 | Carbon Tetrachloride Poisoning | C00002743 | 
| D001930 | Brain Injuries | C00000601 | 
| D002375 | Catalepsy | C00000601 | 
| D018476 | Hypokinesia | C00000601 | 
| D020244 | Infarction, Middle Cerebral Artery | C00000601 | 
| D020734 | Parkinsonian Disorders | C00000601 |